Related Experiment Video
Updated: Nov 4, 2025
12:04
Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
29.1K
Small Cell Neuroendocrine Cervical Carcinoma: A Case Report
Malihe Hasanzadeh1, Nooshin Babapour2, Marjaneh Farazestanian1
1Department of Obstetrics and Gynecology, Women's Health Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Journal of Family & Reproductive Health
|May 31, 2021
Summary
Small cell neuroendocrine cervical carcinoma is a rare, aggressive cancer. Early recognition through IHC analysis and multimodal therapy are crucial for improving patient survival rates.
Area of Science:
- Gynecologic Oncology
- Pathology
- Oncology
Background:
- Small cell neuroendocrine cervical carcinoma is a rare and aggressive malignancy, accounting for 0.5-3% of cervical tumors.
- This tumor type is characterized by rapid progression and early metastasis via lymphogenous and hematogenous routes.
Observation:
- A 40-year-old woman diagnosed with stage IB2 cervical cancer underwent radical hysterectomy.
- The initial diagnosis was squamous cervical cancer, but the disease recurred rapidly 50 days post-surgery with a 6 cm vaginal cuff tumor.
Findings:
- Pathological review confirmed the diagnosis of small cell neuroendocrine cervical carcinoma.
- Immunohistochemistry (IHC) analysis is vital for accurate histopathological identification of this specific entity.
Implications:
- Accurate diagnosis of small cell neuroendocrine cervical carcinoma is critical for appropriate treatment planning.
- Multimodality therapeutic approaches, including chemoradiotherapy, may enhance survival outcomes for patients with this rare cancer.
